We and others have recently shown that loss of the mitochondrial membrane potential (⌬) precedes apoptosis and chemical-hypoxia-induced necrosis and is prevented by Bcl-2. In this report, we examine the biochemical mechanism used by Bcl-2 to prevent ⌬ loss, as determined with mitochondria isolated from a cell line overexpressing human Bcl-2 or from livers of Bcl-2 transgenic mice. Although Bcl-2 had no effect on the respiration rate of isolated mitochondria, it prevented both ⌬ loss and the permeability transition (PT) induced by various reagents, including Ca 2؉ , H 2 O 2 , and tert-butyl hydroperoxide. Even under conditions that did not allow PT, Bcl-2 maintained ⌬, suggesting that the functional target of Bcl-2 is regulation of ⌬ but not PT. Bcl-2 also maintained ⌬ in the presence of the protonophore SF6847, which induces proton inf lux, suggesting that Bcl-2 regulates ion transport to maintain ⌬. Although treatment with SF6847 in the absence of Ca 2؉ caused massive H ؉ inf lux in control mitochondria, the presence of Bcl-2 induced H ؉ eff lux after transient H ؉ inf lux. In this case, Bcl-2 did not enhance K ؉ eff lux. Furthermore, Bcl-2 enhanced H ؉ eff lux but not K ؉ f lux after treatment of mitochondria with Ca 2؉ or tert-butyl hydroperoxide. These results suggest that Bcl-2 maintains ⌬ by enhancing H ؉ eff lux in the presence of ⌬-loss-inducing stimuli.
The protooncogene bcl-2 is activated by the t(14;18) chromosomal translocation in follicular lymphoma (1) (2) (3) and can prevent apoptosis and some forms of cellular necrosis (4) (5) (6) , although the detailed mechanisms of its anti-cell-death function remain unknown. Bcl-2 has been shown to localize in multiple membrane compartments, including the mitochondria (7, 8) . Several models have been proposed to explain how Bcl-2 blocks cell death: (i) by sequestering the proforms of caspases by indirect interaction (9-11), (ii) by forming ionic channels (12, 13) , and (iii) by inhibiting apoptosis-associated release of cytochrome c from the mitochondria, which leads to the activation of the caspase 3 (14, 15) . However, all these models lack direct evidence of direct involvement in the anti-cell-death function of Bcl-2. Recently, we (16) and others (17) have reported that mitochondrial dysfunction such as membrane potential (⌬) loss and the permeability transition (PT) precedes cell death and is prevented by Bcl-2 and Bcl-X L . ⌬, an electrical potential across the inner membrane created by H ϩ pumping during electron transfer, plays a key role in mitochondrial bioenergetics. The PT allows solutes with a molecular weight of less than 1,500 to equilibrate across the inner membrane (18, 19) . It has been proposed that mitochondrial apoptogenic factors might be released through the PT during apoptosis, and in fact, a mitochondrial protein, apoptosis-inducing factor, which has the ability to induce apoptotic changes of the nucleus in vitro and the activation of caspases, was shown to be released by the PT (20, 21) .
We studied the role of Bcl-2 in preventing ⌬ loss from isolated mitochondria. Our findings suggested that in the presence of ⌬-loss-inducing stimuli, Bcl-2 maintains ⌬ by enhancing proton efflux.
MATERIALS AND METHODS
Chemicals and Protein Purification. SF6847 and bongkrekic acid were kindly provided by H. Terada and Y. Shinohara (Tokushima University, Japan), bongkrekic acid was also obtained from M. Klingenberg (University of Munich, F.R.G.). H]acetate were purchased from Amersham. 2Ј,7Ј-Bis(carboxyethyl)-5(6)-carboxyf luorescein (BCECF) was from Funakoshi (Tokyo). Other chemicals were from Wako Biochemicals (Osaka). Recombinant glutathione S-transferase (GST)-Bak fusion and GST proteins were expressed in Escherichia coli (strain XL͞C) and purified by affinity chromatography on a glutathione-agarose column (Sigma).
Cell Line. Human bcl-2 cDNA was inserted in the pUC-CAGGS vector (22) and transfected into AH130 cells (23) by electroporation. Expression of Bcl-2 protein was confirmed by Western blot analysis. Cell viability was measured by propidium iodide staining as described elsewhere (16) .
Isolation of Mitochondria. AH130 cells and AH130-Bcl-2 cells were injected into the abdominal cavity of a Donryu rat. Seven days after injection, ascites fluid was collected. Transgenic mice expressing the human bcl-2 gene in their livers have been described elsewhere (24) .
After centrifugation of the ascites fluid, the cell pellet was treated with 7.8 mM sodium phosphate (pH 7.4) to disrupt red cells. After washing by centrifugation, the cells were homogenized with a glass-Teflon Potter homogenizer. Mouse livers were homogenized similarly. Mitochondria were isolated in 0.3 M mannitol͞10 mM potassium Hepes, pH 7.4͞0.2 mM EGTA, pH 7.4͞0.1% fatty acid-free BSA by centrifugation at 2,500 ϫ g for 10 min. The mitochondria were washed twice with this medium without EGTA to which 5 mM potassium phosphate was added and then suspended in it (25) . Bcl-2 protein expression in the mitochondria was assessed by Western blot analysis.
Measurement of Biochemical Parameters. All experiments using isolated mitochondria, except for those with the tert-butyl hydroperoxide (tBuOOH) and Ca 2ϩ treatment and for ion measurement, were performed in buffer containing 0.3 M mannitol, 10 mM potassium Hepes (pH 7.4), 5 mM potassium phosphate (pH 7.4), 1 mM EDTA (pH 7.4), 0.1% fatty acid-free BSA, rotenone (1 g͞ml), and 10 mM succinate. For experiments with tBuOOH and Ca 2ϩ , EDTA was omitted, and for ion measurement, potassium Hepes was omitted to reduce the buffer action. In the experiments using Bak protein, mitochondria were preincubated with GST-Bak or GST protein for 30 min at 37°C in the buffer as described (26) , and ⌬ was measured. Mitochondrial respiration was measured with an O 2 electrode. Respiration rates in state IV and state III were measured by the addition of 5 mM potassium succinate (pH 7.4), as substrate, or potassium succinate plus 0.3 mM ADP, respectively. Membrane potential was measured by a tetraphenylphosphonium chloride (TPP ϩ ) electrode and͞or rhodamine 123 (Rh123) uptake (27) . Mitochondrial swelling, the activity of aspartate aminotransferase, and the ATP concentration were measured as described elsewhere (25 (27) and BCECF (28) , respectively.
RESULTS AND DISCUSSION
To explore the biochemical basis by which Bcl-2 acts to maintain ⌬ during cell death, isolated mitochondria were used. Mitochondria were purified from two different sources: the rat ascites hepatoma cell line AH130 (23) and mouse livers. Mitochondria with overexpressed human Bcl-2 (Bcl-2 mitochondria) were obtained from human bcl-2 transfected AH130 and from the livers of bcl-2 transgenic mice in which human Bcl-2 expression is restricted to the liver (24) . It has been shown that overexpression of Bcl-2 in the transgenic mice exerts a preventive effect on anti-Fas antibody-induced hepatic failure (24) . Overexpression of Bcl-2 in AH130 efficiently prevented apoptosis induced by various reagents, including H 2 O 2 (Fig. 1A) . H 2 O 2 -induced apoptosis was also inhibited by two inhibitors of PT, cyclosporin A (CsA) and bongkrekic acid ( Fig. 1 A) , strongly suggesting the direct involvement of mitochondrial dysfunction in apoptosis and confirming previous observations (17) .
The presence of human Bcl-2 in Bcl-2 mitochondria but not in control mitochondria was verified by Western blot analysis (Fig. 1B) . Bcl-2 levels in AH130-Bcl-2 mitochondria were 10-fold higher than in transgenic-Bcl-2 mitochondria. Endogenous Bcl-2 was not detected in any mitochondria tested with an anti-mouse Bcl-2 polyclonal antibody that also crossreacted with rat Bcl-2 (data not shown), consistent with extremely low levels or absence of bcl-2 mRNA in the liver (29, 30) . The respiratory rate (RR) was measured by O 2 consumption in state III and state IV, and the respiratory control ratio (RCR, defined as the ratio of RR in state III to state IV) showed no significant changes in the presence of Bcl-2. The RCR [RR (nmol of O 2 per mg of protein per min) in state III͞RR in state IV] was 76 Ϯ 6͞18 Ϯ 3 for AH130 mitochondria, 72 Ϯ 6͞16 Ϯ 6 for AH130-Bcl-2 mitochondria, 97 Ϯ 5͞19 Ϯ 2 for nontransgenic mitochondria, and 105 Ϯ 9͞18 Ϯ 3 for transgenic-Bcl-2 mitochondria. Similarly, the P͞O ratio (amount of synthesized ATP divided by oxygen consumption in state III) showed no significant changes in the presence of Bcl-2 (1.64 Ϯ 0.32 for AH130 mitochondria, 1.73 Ϯ 0.26 for AH130-Bcl-2 mitochondria, 1.82 Ϯ 0.21 for nontransgenic mitochondria, and 1.93 Ϯ 0.33 for transgenic-Bcl-2 mitochondria). These data suggested that Bcl-2 had little, if any, effect on mitochondrial bioenergetics under normal conditions. When AH130 mitochondria (1 mg of protein per ml) were treated with Ca 2ϩ (Fig. 1C ) or H 2 O 2 ( Fig. 1D ), ⌬ was reduced in a concentration-dependent manner as assessed by using a TPP ϩ electrode, whereas the decrease of ⌬ was considerably smaller in AH130-Bcl-2 mitochondria. A similar effect of Bcl-2 on ⌬ was observed in liver mitochondria treated with H 2 O 2 ( Fig. 1E ), Ca 2ϩ , or antimycin A and was also observed by using low concentrations of mitochondria (0.1 mg of protein per ml; data not shown). These results indicated that Bcl-2 acts to maintain ⌬ in isolated mitochondria exposed to ⌬-lossinducing reagents. To examine whether the maintenance of ⌬ by Bcl-2 in vitro was related to antiapoptotic activity, we tested the effect of the proapoptotic Bak protein in the Bcl-2 family (31-33) on mitochondrial ⌬. Incubation of nontransgenic mitochondria with recombinant GST-Bak fusion protein resulted in a decrease of ⌬ in a concentration-dependent manner (Fig. 1F) , whereas GST (as a control) induced no ⌬ loss, strongly suggesting that the maintenance of ⌬ by Bcl-2 reflects its antiapoptotic activity.
Several recent reports (16, 17) have suggested that Bcl-2 prevents the apoptosis-associated PT of the mitochondrial membrane. Because the decrease of ⌬ leads to PT and, conversely, PT results in ⌬ loss (19), we attempted to determine which of these phenomena was the primary target of Bcl-2. AH130 mitochondria treated with the reactive oxygen species tBuOOH showed both ⌬ loss ( Fig. 2A, trace 1 ) and the PT (Fig. 2B, trace 1, and C) . Induction of the PT by tBuOOH was almost completely inhibited by CsA (Fig. 2B, trace 2) , which has been shown to inhibit PT completely in some cases (Fig. 2 A, trace 2) . In contrast, AH130-Bcl-2 mitochondria treated with tBuOOH showed inhibition of both ⌬ loss and PT ( Fig. 2 A and B, traces 3 , and Fig. 2C ), suggesting that Bcl-2 acts to inhibit ⌬ loss rather than PT. Furthermore, in the absence of Ca 2ϩ the protonophore SF6847 induced ⌬ loss (Fig. 2D) but not PT (data not shown) in AH130 mitochondria, and Bcl-2 still maintained ⌬ under these conditions (Fig. 2D) . Similar results were obtained with hypoxia or treatment with antimycin A without Ca 2ϩ , both of which caused ⌬ loss but not PT (data not shown), and the same findings were also observed in mouse liver mitochondria (data not shown). Thus, we concluded that ⌬ but not PT was the target of Bcl-2 action.
In mitochondria, the proton pump generates ⌬ and the pH gradient, and addition of drugs such as ionophores alters the distribution of ions across the inner membrane, affecting ⌬ and the pH gradient. Because Bcl-2 maintained ⌬ even in the presence of protonophores such as SF6847 (Fig. 2D) or carbonylcyanide m-chlorophenylhydrazone (Fig. 2E) or ionophores such as valinomycin (Fig. 2F) , which are known to directly facilitate the transport of protons and potassium ions, respectively, into the matrix space and to reduce ⌬, it is conceivable that Bcl-2 maintained ⌬ by acting as an ion transporter or as a regulator of the ion transport generating ⌬. Therefore, we examined the effects of Bcl-2 on ion transport across the mitochondrial membrane. Our isolated mitochondrial system contained mainly protons and potassium ions as cations and phosphate and hydroxyl ions as anions. From technical reasons and also because of previous observations that the Bcl-X L ion channel in a synthetic lipid membrane showed more selectivity for cations than anions (12), we focused on two cations, H ϩ and K M. In the presence of Bcl-2, SF6847 also induced a transient decrease of the external H ϩ concentration (Fig. 3B ). This transient decrease was followed by an increase to nearly the original level, which was not observed in nontransgenic mitochondria. Thus, the changes of the external and matrix H ϩ concentrations of transgenic-Bcl-2 mitochondria were from 7.59 ϫ 10 Ϫ8 M to 7.16 ϫ 10 Ϫ8 M and from 2.29 ϫ 10 Ϫ8 M to 2.85 ϫ 10 Ϫ8 M, respectively. These values would underestimate the total amount of H ϩ transported because of the buffer action, which was clearly shown in the elevation of the H ϩ concentration by only 50 nM after addition of 1 M HCl to mitochondrial suspension (Fig. 3B, arrow b) . Thus, the actual amount of H ϩ transported must be larger than that simply calculated from the difference in H ϩ concentrations.
The ⌬pH values calculated from these data during 40 nM SF6847 treatment (from 0.53 to 0.01 in nontransgenic mitochondria and from 0.52 to 0.4 in transgenic-Bcl-2 mitochondria) were very close to those obtained by the [ 3 H]acetic acid assay (Fig. 3D) . Given that K ϩ efflux also contributes to ⌬, the external K ϩ concentration increased less with transgenicBcl-2 mitochondria than nontransgenic mitochondria (Fig.  3C) , indicating that the maintenance of ⌬ by Bcl-2 does not depend on K ϩ efflux. ADP-induced ⌬ loss, which is mainly caused by H ϩ influx through F 0 F 1 ATPase, is reflected in a small decrease of the external H ϩ concentrations ( Fig. 3 A and  B, arrow a) . In contrast, SF6847 induced a much larger decrease of the external H ϩ concentration (Fig. 3B, arrows  1-4) , which was sufficient to reduce ⌬ (Fig. 3A, arrows 1-4) . These results strongly suggest that the maintenance of ⌬ by Bcl-2 is achieved mainly by enhanced H Proc. Natl. Acad. Sci. USA 95 (1998) transgenic and transgenic-Bcl-2 mitochondria was 0.82 Ϯ 0.13 and 1.02 Ϯ 0.24 l͞mg of protein, respectively). Addition of Ca 2ϩ or tBuOOH induced ⌬ loss in nontransgenic mitochondria but had little effect on transgenic-Bcl-2 mitochondria (Fig. 4 A and D) . Although Bcl-2 had little effect on K ϩ influx (Fig. 4 C and F) , transgenic-Bcl-2 mitochondria showed much larger H ϩ efflux after addition of Ca 2ϩ or tBuOOH (Fig. 4 B and E) and ⌬pH maintenance (data not shown) than nontransgenic mitochondria (Fig. 4 B and E) . Thus, the data indicate that Bcl-2 maintains ⌬ by directly or indirectly enhancing H ϩ efflux.
H ϩ is mainly pumped out from mitochondria by two different mechanisms, via electron transfer complexes or the reverse action of F 0 F 1 ATPase (34). Therefore, we next examined which mechanism was involved in enhancement of H ϩ efflux by Bcl-2. To explore the possible involvement of electron transfer complexes, we measured the O 2 consumption rate. As shown in Fig. 5A , addition of SF6847 enhanced the respiration of nontransgenic mitochondria, due to loss of the proton gradient by the direct action of the protonophore. In contrast, in transgenic-Bcl-2 mitochondria, SF6847-induced respiration was much slower than in nontransgenic mitochondria, suggesting that enhancement of H ϩ efflux by Bcl-2 did not occur via the electron transport system or at least not via complex IV where oxygen is consumed. Similar results were obtained in mitochondria treated with Ca 2ϩ (Fig. 5B) . In addition, Bcl-2 had little effect on the state IV respiration rate after treatment with tBuOOH (Fig. 5C) . Similarly, reduction of ⌬ and ⌬pH was induced by the complex IV inhibitor KCN (Fig. 6 A and  B) but was prevented by Bcl-2 without enhancing O 2 consumption (Fig. 6C) . These results suggested that electron transfer complexes were not directly involved in the enhancement of H ϩ efflux by Bcl-2, consistent with the observations that Bcl-2 has an anti-cell-death action in cells lacking mitochondrial DNA (35) and in cells under hypoxic conditions (36, 37) , although the possibility was not excluded that part of the electron transfer complex was modified by Bcl-2. To examine the possible involvement of the reverse action of F 0 F 1 ATPase, which consumes ATP to enhance H ϩ efflux in the presence of Bcl-2, mitochondrial ATP concentrations were measured. As shown in Fig. 5 D-F , the ATP concentration of transgenicBcl-2 mitochondria was higher than that of nontransgenic mitochondria after treatment with SF6847, Ca The H ϩ gradient is the most fundamental element in maintaining mitochondrial function. Mitochondrial homeostasis, including the distribution of ions, is mainly regulated by the H ϩ synport or antiport. Although the biochemical mechanisms underlying the regulation of ⌬ by Bcl-2 through H ϩ efflux remain to be elucidated, one possibility is that Bcl-2 acts in concert with part of the electron transport system. In this context, it was shown in Caenorhabditis elegans that ced-9, a bcl-2 homologue, and cyt-1, which encodes a component of the respiratory chain, are cotranscribed from the same mRNA, suggesting that Ced-9 and Cyt-1 might function in the same system (38) . Bcl-2 might be associated with as yet undefined proton pumps. Alternatively, Bcl-2 might itself induce H ϩ efflux. Structural and electrophysiological analysis has shown that Bcl-X L and Bcl-2 could form ionic channels in a synthetic lipid membrane (12, 13) , consistent with the proposed three- (1998) dimensional structure of the protein (39) . The activity of Bcl-2 as an ionic channel might underlie part of its effect on H ϩ transport.
In conclusion, our data indicate that Bcl-2 directly or indirectly enhances H ϩ efflux to maintain ⌬. Among the ions in our experimental system (H ϩ , K ϩ , phosphate, and hydroxy ions), H ϩ but not K ϩ contributed to the maintenance of ⌬ by Bcl-2 in the presence of apoptotic stimuli. Although we cannot exclude the possibility that Bcl-2 regulates anions, it seems unlikely that it regulated the flux of phosphate ions to counteract proton efflux, considering the different behavior of H ϩ and K ϩ .
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